Locoregional effects of microbiota in a preclinical model of colon carcinogenesis

Cancer Research

Volumn 77, Issue 10, 2017, Pages 2620-2632

  Tomkovich, Sarah ^a,b   Yang, Ye ^a   Winglee, Kathryn ^c   Gauthier, Josee ^a   Mühlbauer, Marcus ^a   Sun, Xiaolun ^a   Mohamadzadeh, Mansour ^d   Liu, Xiuli ^a   Martin, Patricia ^e,f   Wang, Gary P ^a   Oswald, Eric ^e,f   Fodor, Anthony A ^c   Jobin, Christian ^a,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Charlotte   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UMR 1220 TCEM (INRA ENITAB)   (France)

^f TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; APC PROTEIN; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MICROBIOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANCER LOCALIZATION; COLON CARCINOGENESIS; COLON FLORA; CONTROLLED STUDY; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SPECIES COMPOSITION; TUMOR PROMOTION; ANIMAL; BACTERIUM; CELL TRANSFORMATION; CLASSIFICATION; COLORECTAL NEOPLASMS; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; INFLAMMATION; INTESTINE FLORA; KNOCKOUT MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BACTERIA; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 85020165403     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-16-3472     Document Type: Article

References (50)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2. The Cancer Genome Atlas Network.Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487: 330-7.
3. Borges-Canha M, Portela-Cidade JP, Dinis-Ribeiro M, Leite-Moreira AF, Pimentel-Nunes P. Role of colonicmicrobiota in colorectal carcinogenesis: a systematic review. Rev Esp Enferm Dig 2015;107:659-71.
4. Brennan CA, Garrett WS. Gut Microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol 2016;70:395-411.
5. Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol 2016;17:230-40.
6. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med 2015;372:1441-52.
7. Jackstadt R, Sansom OJ. Mouse models of intestinal cancer. J Pathol 2016;238:141-51.
8. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247:322-4.
9. Dove WF, Clipson L, Gould KA, Luongo C, Marshall DJ, Moser AR, et al. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 1997; 57:812-4.
10. Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 2012;33:1231-8.
11. Cooper HS, Everley L, Chang WC, Pfeiffer G, Lee B, Murthy S, et al. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology 2001;121:1407-16.
12. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012;491: 254-8.
13. Huang EH, Park JC, Appelman H, Weinberg AD, Banerjee M, Logsdon CD, et al. Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice. Surgery 2006;139:782-8.
14. Dennis KL, Wang Y, Blatner NR, Wang S, Saadalla A, Trudeau E, et al. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res 2013;73:5905-13.
15. Dennis KL, Saadalla A, Blatner NR, Wang S, Venkateswaran V, Gounari F, et al. T-cell Expression of IL10 is essential for tumor immune surveillance in the small intestine. Cancer Immunol Res 2015;3:806-14.
16. Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, Yen H-R, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016-22.
17. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
18. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/b-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195-206.
19. Abed J, Emgård JEM, Zamir G, Faroja M, Almogy G, Grenov A, et al. Fap2 mediates fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 2016;20:215-25.
20. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacteriumnucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015; 42:344-55.
21. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000;97:6640-5.
22. Nougayrede J-P, Homburg S, Taieb F, BouryM, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006;313:848-51.
23. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207-15.
24. Yu Y-N, Yu T-C, Zhao H-J, Sun T-T, Chen H-M, Chen H-Y, et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis bymodulating the tumor microenvironment. Oncotarget 2015;6:32013-26.
25. Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development inmice by activating Toll-like receptor 4 signaling to nuclear factorκ, up-regulating expression of microRNA-21. Gastroenterology 2017;152:851-866.e24.
26. Pope JL, Tomkovich S, Yang Y, Jobin C. Microbiota as a mediator of cancer progression and therapy. Transl Res 2017;179:139-54.
27. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13:800-12.
28. Kwong LN, Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol 2009;656:85-106.
29. Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 2014;20:859-67.
30. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010;1:138-47
31. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320-9.
32. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE 2013;8:e70803.
33. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 2013; 66:462-70.
34. Baxter NT, Zackular JP, Chen GY, Schloss PD. Structure of the gut microbiome following colonizationwith human feces determines colonic tumor burden. Microbiome 2014;2:20.
35. Zackular JP, Baxter NT, Iverson KD, SadlerWD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. MBio 2013;4: e00692-13.
36. Zhan Y, Chen P-J, Sadler WD, Wang F, Poe S, NunezG, et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res 2013;73:7199-210.
37. Zackular JP, Baxter NT, Chen GY, Schloss PD. Manipulation of the gut microbiota reveals role in colon tumorigenesis. mSphere 2016;1:e00001. doi: 10.1128/mSphere.00001-15.
38. Cochrane KLS. Elucidating potential virulence factors in Fusobacterium nucleatum [Internet] [Doctoral dissertation]. The University of Guelph; 2016. Available from: https://atrium.lib.uoguelph.ca/xmlui/bitstream/handle/10214/9623/Cochrane-Kyla-201605-PhD.pdf?sequence=3.
39. Kaplan CW, Ma X, Paranjpe A, Jewett A, Lux R, Kinder-Haake S, et al. Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun 2010;78: 4773-8.
40. Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, et al. Identification and characterization of a novel adhesin unique to oral fusobacteria. J Bacteriol 2005;187:5330-40.
41. Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 2014;63: 1932-42.
42. Martin P, Marcq I, Magistro G, Penary M, Garcie C, PayrosD, et al. Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli. PLoS Pathog 2013;9:e1003437.
43. Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, et al. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem 2011;286:35562-70.
44. Tronnet S, Garcie C, Rehm N, Dobrindt U, Oswald E, Martin P. Iron homeostasis regulates the genotoxicity of escherichia coli that produces colibactin. Infect Immun 2016;84:3358-68.
45. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015;347:78-81.
46. Wu S, Powers S, Zhu W, Hannun YA. Substantial contribution of extrinsic risk factors to cancer development. Nature 2016;529:43-7.
47. Podolskiy DI, Gladyshev VN. Intrinsic versus extrinsic cancer risk factors and aging. Trends Mol Med 2016;22:833-4.
48. O'Sullivan O, Cronin O, Clarke SF, Murphy EF, Molloy MG, Shanahan F, et al. Exercise and the microbiota. Gut Microbes 2015;6:131-6.
49. Conlon MA, Bird AR. The impact of diet and lifestyle on gutmicrobiota and human health. Nutrients 2015;7:17-44.
50. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14:e1002533.